<?xml version="1.0" encoding="UTF-8"?>
<p id="Par17">In summary, our network proximity analyses offer multiple candidate repurposable drugs that target diverse cellular pathways for potential prevention and treatment of 2019-nCoV/SARS-CoV-2. However, further preclinical experiments
 <sup>
  <xref ref-type="bibr" rid="CR64">64</xref>
 </sup> and clinical trials are required to verify the clinical benefits of these network-predicted candidates before clinical use.
</p>
